CT-P13: Clinical Trials

6 trials of CT-P13, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 unknown. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Recruiting 1, Unknown 1
Phase 21Completed 1

Follow CT-P13: new trials by email Literature Review of CT-P13 trials Research Report on CT-P13

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC
CT-P13 - Inflammatory Bowel Diseases
Phase 3UnknownCMC Ambroise Paré1302024-07-102024-07-31
InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
Infliximab subcutaneous, Immunosuppressive Agents - Inflammatory Disease, Disease Crohn
Phase 3RecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1582021-11-252024-12-10
MIS-C Comparative Effectiveness Study
Infliximab, Anakinra, Methylprednisolone - Multisystem Inflammatory Syndrome-Children
Phase 2 / Phase 3CompletedUniversity of California, San Diego732020-12-222025-11-04
To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis
CT-P13, Remicade - Rheumatoid Arthritis
Phase 3CompletedCelltrion2702018-11-122021-09-14
A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA
CT-P13 - Rheumatoid Arthritis
Phase 3CompletedCelltrion4072016-09-122020-04-08
Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease
CT-P13, Remicade - Crohn's Disease
Phase 3CompletedCelltrion2202014-09-192018-05-09

Conditions studied

Crohn Disease (3)  ·  Arthritis, Rheumatoid (2)  ·  Colitis, Ulcerative (1)  ·  Inflammatory Bowel Diseases (1)  ·  Intestinal Diseases (1)

Sponsors

Celltrion (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  CMC Ambroise ParĂ© (1)  ·  University of California, San Diego (1)

Countries

United States (2)  ·  China (1)  ·  France (1)  ·  Netherlands (1)  ·  South Korea (1)

Top investigators

Adriana Tremoulet, MD, MAS (1)  ·  Dr. G D'Haens, Phd MD (1)  ·  MoonSun Choi (1)  ·  Yoram Bouhnik, PhD.Med. (1)

Results publications

PMID 29411318, PMID 30929895, PMID 33230526, PMID 33245751, PMID 33676969, PMID 34216825, PMID 35435862, PMID 35673354, PMID 36534825, PMID 36694613, PMID 42617793

NIH funding

2016 (1)